Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: A pilot study at 12-month follow-up

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 8, 2011, Pages 1159-1166

  Arevalo, J Fernando ^a   Espinoza, Juan V ^a  

^a Clinica Oftalmologica Centro Caracas   (Venezuela)

Author keywords

Anti VEGF; Avastin; Bevacizumab; Chronic central serous chorioretinopathy; Intravitreal injections; Pegaptanib; Photodynamic therapy

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; VASCULOTROPIN INHIBITOR; VERTEPORFIN;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; CENTRAL MACULAR THICKNESS; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; MEAN LOGARITHM MINIMUM ANGLE OF RESOLUTION; MONOTHERAPY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL RESOLUTION; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PILOT STUDY; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY; TREATMENT DURATION; VISUAL SYSTEM PARAMETERS;

ADULT; ANTIBODIES, MONOCLONAL; APTAMERS, NUCLEOTIDE; CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC DISEASE; COMBINED MODALITY THERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PORPHYRINS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 80052774666     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1651-7     Document Type: Article

References (29)

1. D Bujarborua S Chatterjee A Choudhury G Bori AK Sarma 2005 Fluorescein angiographic features of asymptomatic eyes in central serous chorioretinopathy Retina 25 422 429 15933587 10.1097/00006982-200506000-00005 (Pubitemid 40791878)
2. M Wang IC Munch PW Hasler C Prünte M Larsen 2008 Central serous chorioretinopathy. Review article Acta Ophthalmol 86 126 145 17662099 10.1111/j.1600-0420.2007.00889.x
3. LA Yannuzzi 1987 Type A behavior and central serous chorioretinopathy Retina 7 111 131 3306853 10.1097/00006982-198700720-00009 1:STN:280: DyaL2szhvFSqsQ%3D%3D (Pubitemid 17136150)
4. RH Loo IU Scott HW Flynn Jr JDM Gass TG Murray ML Lewis PJ Rosenfeld WE Smiddy 2002 Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy Retina 22 19 24 11884873 10.1097/00006982-200202000-00004 (Pubitemid 41070746)
5. M Taban DS Boyer EL Thomas 2004 Chronic central serous chorioretinopathy: photodynamic therapy Am J Ophthalmol 137 1073 1080 15183792 10.1016/j.ajo.2004.01.043 (Pubitemid 38759356)
6. Gass JDM (1997) Stereoscopic atlas of macular diseases: diagnosis and treatment, 4th edn. Mosby, St. Louis, pp 52-70
7. F Cardillo R Rigault G Ravera CM Eandi L Ventre A Abdollahi M Manea 2005 The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy Am J Ophthalmol 139 87 99 10.1016/j.ajo.2004.08.037 (Pubitemid 40094844)
8. E Ergun M Tittl M Stur 2004 Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy Arch Ophthalmol 122 37 41 14718292 10.1001/archopht.122.1.37 1:CAS:528:DC%2BD2cXhtVWrsLY%3D (Pubitemid 38063602)
9. W-M Chan TYY Lai RYK Lai EWH Tang DTL Liu DSC Lam 2008 Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy Retina 28 85 93 18185143 10.1097/IAE.0b013e318156777f
10. PM Battaglia S Da Pozzo G Ravalico 2003 Photodynamic therapy in chronic central serous chorioretinopathy Retina 23 235 237 10.1097/00006982-200304000- 00016 (Pubitemid 36548818)
11. NM Bressler 1999 Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trial-TAP report no. 1 Arch Ophthalmol 117 1329 1345 1:CAS:528:DyaK1MXntVWgtr8%3D (Pubitemid 30029343)
12. U Schlotzer-Schrehardt A Viestenz GO Naumann, et al. 2002 Dose-related structural effects of photodynamic therapy in human eyes Arch Ophthalmol 240 748 757 10.1007/s00417-002-0517-4
13. W-M Chan TYY Lai DTL Liu DSC Lam 2007 Intravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin Am J Ophthalmol 143 977 983 17459318 10.1016/j.ajo.2007.02.039 1:CAS:528: DC%2BD2sXlvVaktbc%3D (Pubitemid 46764660)
14. PY Lee KS Kim WK Lee 2009 Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy Jpn J Ophthalmol 53 52 56 19184311 10.1007/s10384-008- 0613-z
15. W-M Chan DSC Lam TYY Lai BSM Tam DTL LIU CKM Chan 2003 Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level Br J Ophthalmol 87 1453 1458 14660450 10.1136/bjo.87.12.1453 (Pubitemid 38010546)
16. F Cardillo CM Eandi L Ventre R De la Longrais FM Grignolo 2003 Photodynamic therapy for central serous chorioretinopathy Retina 23 752 763 10.1097/00006982-200312000-00002 (Pubitemid 38040573)
17. LA Yannuzzi JS Slakter NE Gross RF Spaide DLL Costa SJ Huang JM Klancnik Jr A Aizman 2003 Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy. A pilot study Retina 23 288 298 12824827 10.1097/00006982-200306000-00002 (Pubitemid 36792972)
18. MB Parodi SDA Pozzo G Ravalico 2003 Photodynamic therapy in chronic central serous chorioretinopathy Retina 23 235 237 10.1097/00006982-200304000- 00016 (Pubitemid 36548818)
19. U Schmidt-Erfurth T Hasan 2000 Mechanism of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration Surv Ophthalmol 45 195 214 11094244 10.1016/S0039-6257(00)00158-2 1:STN:280:DC%2BD3M7gslKjsA%3D%3D
20. MF Niegel NF Schrage S Christmann RF Degenring 2008 Intravitreal bevacizumab for chronic central serous chorioretinopathy Ophthalmologe 105 943 945 18214491 10.1007/s00347-008-1691-5 1:STN:280:DC%2BD1M7ktVaktw%3D%3D
21. ME Torres-Soriano G García-Aguirre V Kon-Jara O Ustariz-Gonzáles M Abraham-Marín MD Ober H Quiroz-Mercado 2008 A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports) Graefes Arch Clin Exp Ophthalmol 246 1235 1239 18523796 10.1007/s00417-008-0856-x 1:CAS:528:DC%2BD1cXovFOntL4%3D
22. KB Schaal AE Hoeh A Scheuerle F Schuett S Dithmar 2009 Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy Eur J Ophthalmol 19 613 617 19551677
23. SJ Lim MI Roh OW Kwon 2010 Intravitreal bevacizumab injection for central serous chorioretinopathy Retina 30 100 106 20010322 10.1097/IAE. 0b013e3181bcf0b4
24. MS Spitzer E Yoeruek A Sierra B Wallenfels-Thilo U Schraermeyer B Spitzer, et al. 2007 Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (lucentis) on different ocular cells Graefes Arch Clin Exp Ophthalmol 245 1837 1842 17347807 10.1007/s00417-007-0568-7 1:CAS:528:DC%2BD2sXhtlWrtrrN (Pubitemid 350154019)
25. Y Hatta K Ishikawa H Nishihara S Ozawa Y Ito H Terasaki 2010 Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography Retina 30 495 502 19996828 10.1097/IAE. 0b013e3181bcedbe
26. WM Chan TY Lai RY Lai DT Liu DS Lam 2008 Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial Ophthalmology 115 1756 1765 18538401 10.1016/j.ophtha.2008.04.014
27. JM Stewart 2006 Half dose verteporfin PDT for central serous chorioretinopathy Br J Ophthalmol 90 805 806 16782941 10.1136/bjo.2006.093328 1:STN:280:DC%2BD28zms1Witw%3D%3D (Pubitemid 43973978)
28. M Reibaldi N Cardascia A Longo C Furino T Avitabile S Faro M Sanfilippo A Russo MG Uva F Munno V Cannemi M Zagari F Boscia 2010 Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial Am J Ophthalmol 149 307.e2 315.e2 10.1016/j.ajo.2009.08.026
29. JY Shin SJ Woo HG Yu KH Park 2011 Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy Retina 31 119 126 20890242 10.1097/IAE.0b013e3181e378f2